4-NEMD

4-NEMD
IUPAC ime
4-(1-naftalen- 1-iletil)- 1H-imidazol
Identifikatori
CAS broj137967-81-8 ДаY
ATC kodnone
PubChemCID 132110
ChemSpider24531958 ДаY
Hemijski podaci
FormulaC15H14N2
Molarna masa222,285 g/mol
SMILES
  • CC(C1=CC=CC2=CC=CC=C21)C3=CN=CN3
InChI
  • InChI=1S/C15H14N2/c1-11(15-9-16-10-17-15)13-8-4-6-12-5-2-3-7-14(12)13/h2-11H,1H3,(H,16,17)/t11-/m0/s1 ДаY
  • Key:DZSQSLQSMKNVBV-NSHDSACASA-N ДаY

4-NEMD je potentan sedativni lek koji deluje kao selektivni alfa-2 adrenergički agonist. On je blisko srodan sa deksmedetomidinom, ali je nekoliko puta potentniji.[1] Poput drugih alfa-2 agonista, on proizvodi sedativne i mišićno relaksantne efekte, ali ne uzrokuje respiratornu depresiju. On trenutno nema medicinsku primenu, ali je istraživan kao baza za potencijalno novu generaciju alfa-2 agonistnih lekova,[2][3] koji mogu da budu selektivni za različite podtipove alfa-2 receptora.[4] On ima dva izomera, od kojih je (S) izomer potentniji, što je slučaj i sa medetomidinom.[5]

Reference

  1. ^ Hong, SS; Romstedt, KJ; Feller, DR; Hsu, FL; Cupps, TL; Lyon, RA; Miller, DD (1994). „A structure-activity relationship study of benzylic modifications of 4-1-(1-naphthyl)ethyl-1H-imidazoles on alpha 1- and alpha 2-adrenergic receptors”. Journal of Medical Chemistry. 37 (15): 2328—33. PMID 7914537. doi:10.1021/jm00041a011. 
  2. ^ Zhang, X; Yao, XT; Dalton, JT; Shams, G; Lei, L; Patil, PN; Feller, DR; Hsu, FL; George, C (1996). „Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine”. Journal of Medical Chemistry. 39 (15): 3001—13. PMID 8709134. doi:10.1021/jm9506074. 
  3. ^ Zhang, X; De Los Angeles, JE; He, MY; Dalton, JT; Shams, G; Lei, L; Patil, PN; Feller, DR; Miller, DD (1997). „Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket"”. Journal of Medical Chemistry. 40 (19): 3014—24. PMID 9301663. doi:10.1021/jm960642q. 
  4. ^ Lalchandani, SG; Zhang, X; Hong, SS; Liggett, SB; Li, W; Moore Bm, 2nd; Miller, DD; Feller, DR (2004). „Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors”. Biochemical pharmacology. 67 (1): 87—96. PMID 14667931. doi:10.1016/j.bcp.2003.08.043. 
  5. ^ Hong, SS; Romstedt, KJ; Feller, DR; Hsu, FL; George, C; Cupps, TL; Lyon, RA; Miller, DD (1992). „Resolution and adrenergic activities of the optical isomers of 4-1-(1-naphthyl)ethyl-1H-imidazole”. Chirality. 4 (7): 432—8. PMID 1361151. doi:10.1002/chir.530040706. 
  • п
  • р
  • у
Ligandi receptora
α1
α2
β
NET
VMAT
Anabolizam
PAH
TH
AAAD
DBH
PNMT
Katabolizam
[Primarni-amin oksidaza
COMT
Drugi
Prekursori
Kofaktori
Drugi
  • p
  • r
  • u
GABAA receptor
Barbiturati
  • Ultra kratkotrajni
    Kratko/srednje
    trajni
    Dugotrajni
    Negrupisani
    Benzodiazepini
    Kratkotrajni
    Intermedijerno trajni
    Dugotrajni
    Dialkil-fenoli
    Nebenzodijazepini
    Piperidindioni
    Hinazolinoni
    Neuroaktivni steroidi
    Alfa-2-adrenergički
    receptor
    Alfa-adrenergički agonisti
    Melatoninski receptor
    Melatonin
    Histaminski receptor &
    Acetilholinski receptor
    Antihistamini &
    Antiholinergici
    5-HT2A &
    α1- adrenergički
    Selektivni 5-HT2A & α1-adrenergički antagonisti
    GABAB receptor /
    GHB receptor
    GHB Tip
    Oreksinski receptori
    Oreksinski antagonisti
    Drugi receptori/
    negrupisani
    Aldehidi
    Alkini
    Karbamati
    Drugi